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Abstract 
Molecular diagnosis is rarely established in 46,XX testicular (T) disorder 
of sex development (DSD) individuals with atypical genitalia. The Wilms’ tumour 
factor-1 (WT1) gene is involved in early gonadal development in both sexes. 
Classically, WT1 deleterious variants are associated with 46,XY disorders of 
sex development (DSD) due to gonadal dysgenesis. We report a novel 
frameshift WT1 variant identified in a SRY-negative 46,XX testicular DSD girl 
born with atypical genitalia. Target massively parallel sequencing involving 
DSD-related genes identified a novel heterozygous WT1 c.1453_1456del; 
p.Arg485Glyfs*14 variant located in the fourth zinc finger of the protein which is 
absent in the population databases. Segregation analysis and microsatellite 
analysis confirmed the de novo status of the variant that is predicted to be 
deleterious by in silico tools and to increase WT1 target activation in 
crystallographic model. This novel and predicted activating frameshift WT1 
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variant leading to the 46,XX testicular DSD phenotype includes the fourth zinc-
finger DNA-binding domain defects in the genetic aetiology of 46,XX DSD. 
 
Key-words: Disorder of sex development; 46,XX testicular, WT1, atypical 
genitalia 
 
 
 
 
 
 
1. Introduction 
In 46,XX individuals, there is a subset of patients born with male external 
genitalia or atypical genitalia because of the presence of testes or ovotestes, 
named as 46,XX testicular (T) and ovotesticular (OT) disorder of sex 
development (DSD), respectively. Most 46,XX T-DSD are caused by a gain-of-
function in key testicular pathway genes1,2. Approximately 90% of cases are 
caused by translocation of SRY onto the X chromosome, particularly in patients 
with male external genitalia. In contrast, molecular diagnosis is rarely 
established in 46,XX OT-DSD and 46,XX T patients with atypical genitalia1. The 
genetic cause of SRY-negative 46,XX T-DSDs is related to SOX9 upregulation, 
most commonly resulting from its duplication1.  
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WT1 encodes a DNA-binding protein containing four zinc fingers3, which 
is essential for normal mammalian urogenital development4. Classically, its 
pathogenic variants are associated with anomalies of testis development, 
leading to 46,XY DSD5,6. Here, we report a novel heterozygous WT1 variant in 
a girl with 46,XX T-DSD.  
 
2. Subjects and Methods 
Case Report 
A 1-year-old Brazilian girl was born after an uneventful pregnancy with 
atypical genitalia characterized by clitoromegaly, a single perineal opening, and 
a short blind-ending vagina. She was the second child of healthy and 
nonconsanguineous parents. A G-banded karyotyping analysis of 100 
peripheral blood lymphocytes revealed a 46,XX karyotype. She underwent 
feminizing genitoplasty and laparoscopy, which confirmed the presence of a 
hemiuterus. Biopsy of both abdominal gonads revealed testicular tissue with 
seminiferous tubules containing Sertoli cells but not germ cells. At 10 years of 
age, elevated basal FSH levels were detected (16 IU/L) with low basal estradiol 
(<1.83 pmol/L) and testosterone (2.08 nmol/L) levels. Gonadotropin-releasing 
hormone depot stimulation (aGnRH) test showed elevation of testosterone 
levels up to 5.65 nmol/L without an increase in estradiol levels (26.7 pmol/L) at 
24 h after injection.  
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She underwent bilateral gonadectomy, which confirmed the presence of 
bilateral testes with seminiferous tubules containing predominantly Sertoli cells 
with rare germ cells. An immature right uterine tube was also identified. 
Fluorescence in situ hybridization with SRY-specific probes excluded SRY 
translocation. The karyotypes of the gonads were also 46,XX.  
 
Genetic Analysis 
All research procedures followed the tenets of the Declaration of 
Helsinki, were approved by the local Ethics Committee with informed consent 
prior to genetic testing. 
We designed an amplicon-based capture panel against exonic regions of 
63 genes known to be associated with human DSDs and also candidate genes 
for DSD etiology7 (see table S1, Supporting information). 
Target sequences were captured using a custom Sure Select Target 
Enrichment System Kit (Agilent Technologies, Santa Clara, CA, USA). 
Sequencing was performed on the Illumina MiSeq platform (San Diego, CA, 
USA) (see Supporting information). 
Sanger sequencing confirmed the potentially pathogenic variant 
identified by targeted massively parallel sequencing and for segregation 
analysis. The identified variant was classified according to American College of 
Medical Genetics (ACMG) criteria8. 
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Microsatellite analysis with 5 markers (deCODE, Généthon, and 
Marshfield) was performed to assess disease haplotypes in the propositus and 
in her mutation-negative father and sister. Data analysis was performed with 
GeneMapper v3.7 software (Applied Biosystems, Foster City, CA, USA). 
 
In silico Modelling of the p.Arg485Glyfs*14 Variant 
The effect of the mutation on protein stability and function was calculated 
using the COFACTOR server (I-TASSER)9, FoldX RepairPDB10, and 
BuildModel commands (YASARA)11. The in silico interaction energies between 
the p.Arg485Gly WT1 region and DNA fragments for NR5A1, FOXL2, and 
WNT4 were calculated using the FoldX interaction energy.  
 
3. Results  
Target sequencing analysis identified a novel heterozygous frameshift 
WT1 c.1453_1456del variant (see Figure S1, Supporting information), which is 
located in exon 10 and encodes the fourth zinc finger of the protein (Figure 1a 
and 1b). No exonic variants were identified in the other DSD genes. This variant 
is absent in all population databases, including the Brazilian databases. This 
frameshift is predicted to be deleterious by Mutalyzer software12 leading to a 
premature stop codon p.Arg485Glyfs*14. No copy number variation was 
identified. 
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This variant was not identified in the patients’ father and unaffected 
sister, who share the same maternal haplotype with the patient, confirming the 
de novo status of the variant (Figure 1d). The variant is classified as pathogenic 
according to ACMG criteria. 
 
Protein Structure and Functional Modelling of WT1 p.Arg485Glyfs*14  
I-TASSER calculations predicted that the p.R485G variant affects the 
stability of the WT1 fourth zinc finger domain to binding DNA. In the mutant 
model (Figure 2.B), the glycine chain changes the protein conformation (WT1 
C-score: 0.42, WT1 R485G C-score: -1.55) compared to the wild-type (Figure 
2.A). These protein structural and functional findings suggest that the p.R485G 
variant affects the DNA binding activity of WT1. 
The estimated binding enthalpy was 9 kJ/mol for the wild-type complex 
and 17 kJ/mol for the R485G complex, representing a 102% increase in DNA-
binding affinity of R485 WT1 (Figure 2.C). This increased binding enthalpy in 
the mutant complex suggests that p.R485G is a gain-of-function variant that 
increases WT1 target activation. 
 
4. Discussion 
We described a SRY-negative 46,XX T-DSD girl with atypical genitalia 
harbouring a novel and de novo frameshift WT1 variant. This presentation is 
very unusual for 46,XX T-DSD patients. Classically, these patients are 
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characterized by a 46,XX karyotype, male external genitalia, small testis, and 
the absence of Mullerian structures13. Approximately 85% of the patients are 
diagnosed after puberty because of their small testes, gynecomastia, and 
infertility. The other 15% of patients are diagnosed at birth based on atypical 
genitalia13. 
In 46,XY individuals, pathogenic WT1 allelic variants are responsible for 
Denys-Drash and Frasier syndromes, which are characterised by gonadal 
dysgenesis, early childhood cortico-resistant nephrotic proteinuria followed by 
renal failure, and Wilms' tumour or gonadoblastoma5,6. Denys-Drash variants 
are generally located in exons 8 and 9 and Frasier variants are located in intron 
9. 
In 46,XX individuals, two deleterious heterozygous WT1 variants located 
outside the zinc-finger domains were previously described in two patients with 
premature ovarian insufficiency (POI)14. Another two 46,XX gonadal dysgenesis 
patients with steroid-resistant nephropathy harboured variants located in exon 9 
of WT115,16. There is no description of atypical genitalia in any of these affected 
female patients. 
The first description of a WT1 variant causing 46,XX T-DSD was reported 
in 201717. The missense WT1 p.Arg495Gly variant was identified in a syndromic 
boy with microcephaly, normal kidney function, male external genitalia, 
dysgenic testis, and a small uterus17.  
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These findings resemble those reported for the NR5A1 p.Arg92Trp 
pathogenic variant. This variant were also first associated with 46,XY DSD and 
POI18 in 46,XX patients. Later, the NR5A1 p.Arg92Trp variant was identified in 
familial and sporadic patients with 46,XX T and OT-DSD18-20.  
Interestingly, the previously and presently described WT1 alterations 
associated with 46,XX T-DSD are located in the fourth zinc-finger DNA-binding 
domain of the WT1 protein. 
There is one reported pathogenic variant, the p.X518Trp located in exon 
10 of WT1 in two female affected individuals21. In contrast to our frameshift 
variant, this variant leads to WT1 protein elongation of 22 amino acids but 
preserves fourth zinc-finger DNA-binding domain.  
The 46,XX T-DSD phenotype can be explained based on the WT1 role of 
in the ovarian determination pathway22. A previous study showed that the 
number of FOXL2-positive cells was dramatically reduced and SOX9-positive 
cells were observed in Wt1-deficient XX mice gonads23. Additionally, the 
expression of ovary-specific genes (Wnt4, Rspo1, Foxl2, Bmp2, and Fst) was 
also significantly reduced, whereas testis-specific genes expression was 
increased in Wt1-deficient XX gonads at E13.523. 
The mutant p.Arg485Glyfs*14 WT1 protein probably leads to an 
imbalance between the female and male gonadal determination pathway. The 
increased binding enthalpy of WT1 p.Arg485Glyfs*14, observed in the in silico 
model, likely leads to NR5A1 overexpression followed by SOX9 up-regulation 
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and testis differentiation (Figure 4). Further in vitro studies are necessary to 
confirm this hypothesis.  
The intriguing absence of renal manifestations of our patient might be 
due to her young age. The only reported variant in exon 10 (WT1 p.X518Trp) 
led to progressive proteinuria in the female index case and her mother, 
reaching end-stage renal disease at 15 and 22 years old, respectively. The 
propositus also presented with Wilms’ tumour at 9 years old. These data 
indicate the need of follow-up of these individuals.  
 
5. Conclusion 
The identification of a novel and predicted activating frameshift WT1 
variant leading to the 46,XX testicular DSD phenotype includes the fourth zinc-
finger DNA-binding domain defects in the genetic aetiology of 46,XX DSD. 
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Figure Legends: 
 
Figure 1. Schematic representation of the WT1 variant, location on the protein, and 
amino acid conservation. (a) The WT1 is composed of 10 exons and has two alternative 
splice sites (KTS and 17AA). (b) WT1 protein is shown indicating the suppression 
domain (SD), repression domain (R), and activation domain (A) with solid bars and 
zinc fingers (Zn) as waves. The c.1453_1456delCTGT variant is in exon 10, which 
encodes the fourth zinc finger (ZF4) region. The affected amino acid is conserved 
among species. The electropherogram is depicted below. (c) WT1 variant visualization 
using the Integrative Genomics Viewer software: IGV 2.3—Broad 
Institute/MIT/Harvard (d) Pedigree and haplotype of the 46,XX T-DSD girl. The 
affected individual, heterozygous for the WT1 c.1453_1456delCTGT variant, is 
indicated with a filled symbol. DNA from the patient’s mother was not available (NA). 
The de novo status of the variant was confirmed by microsatellite analysis. The 
common haplotype inherited from the patient’s mother is highlighted in a black box and 
by the father in a light grey. 
 
 
Figure 2. Structural analysis of R485G and wild-type WT proteins. (A) WT1 wild-type 
protein prediction; (a) Zoom of the wild-type WT1 fourth zinc finger; (B) R485G 
protein variant prediction; (b) Zoom of the R485G WT1 mutant region; (C) R485G 
functional prediction showing changes in the WT1 zinc finger domain (purple) bound to 
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DNA (grey). The amino acid change promotes structural and functional disruption of 
WT1. 
 
 
Figure 3. Schematic overview of the signaling pathway of ovarian development (a) and 
proposed mechanism of 46,XX DSD testicular in patients with heterozygous WT1 
variant in exon 10 (b). In 46,XX individuals, FOXL2 transcriptionally represses NR5A1 
expression by antagonizing WT1 during gonadal development, leading to suppression 
of the male pathway and activation of the ovarian determination cascade. We 
hypothesized that the WT1 p.R485G*fs14 variant, leads to NR5A1 expression, 
resulting in SOX9 up-regulation and testicular development in this 46,XX T-DSD girl. 
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• The Wilms’ tumour factor-1 (WT1) gene is 
involved in early gonadal development in 
both sexes 
• A novel and de novo heterozygous WT1
c.1453_1456del; p.Arg485Glyfs*14 variant 
was identified in a SRY-negative 46,XX 
testicular DSD girl born with atypical genitalia
• The variant is located in the fourth zinc-finger 
domain of WT1 protein 
• The variant is predicted as activating by in 
silico tools and likely leads to NR5A1
overexpression followed by SOX9 up-
regulation and testis differentiation 
• This novel variant includes the WT1 fourth 
zinc-finger DNA-binding domain defects in 
the genetic aetiology of 46,XX DSD.
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